Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02267616 · ClinicalTrials.gov registry record · NA

Effectiveness of Prolonged Use of IUD/Implant for Contraception

A NA study of Contraception, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
1,076
Enrollment target
2
Study locations

NCT02267616 is a NA study of Contraception that has completed, run by Indiana University. The registered enrollment target is 1,076 participants, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (145% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02267616, a NA study of Contraception, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
1,076 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or having it removed and replaced with a new implant. Participants will be followed for up to three years.

Conditions Studied

Interventions

  • DEVICE Etonogestrel Implant

Study Locations (2)

Indiana

  • Indiana University - Indianapolis

Missouri

  • Washington University in St. Louis School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 1,076 participants
Start Date 2011-12
Est. Completion 2021-03-31
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT02267616

The ClinicalTrials.gov registry entry for NCT02267616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,076 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (145% higher). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Etonogestrel Implant is the first listed.

NCT02267616 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Missouri.

Frequently Asked Questions

What is clinical trial NCT02267616 about?

NCT02267616 is a clinical study titled "Effectiveness of Prolonged Use of IUD/Implant for Contraception". This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or ha...

What is the current status of trial NCT02267616?

This trial is currently completed. It is a NA study. The enrollment target is 1,076 participants. The study started on 2011-12. Estimated completion is 2021-03-31.

What conditions does trial NCT02267616 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT02267616?

The interventions under investigation include: Etonogestrel Implant (DEVICE).

Who is sponsoring clinical trial NCT02267616?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02267616 being conducted?

This trial has 2 study locations across Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.